ADARx Pharmaceuticals, Inc. (ADRX) stock
ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Last filing: 10-Q on Nov 12, 2026
$13.82−0.18 (-1.29%)
Close on Nov 17, 2026Market cap $1.48BP/E –Yield –
ADARx Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
No total debt figures for ADARx Pharmaceuticals
ADARx Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?